724286

Alexion Pharmaceuticals, Inc. — FEI 3006031727

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 13, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
New Haven, CT (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)